High dose of vitamin D supplements improves insulin resistance in obese kids

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-11-05 06:45 GMT   |   Update On 2022-11-05 06:47 GMT

A new study published in the European Journal of Pediatrics suggests that a high dose of vitamin D supplementation (above 4000 IU/d) might improve insulin resistance and lower a number of cardiometabolic risk markers on child and adolescent overweight/obesity (OW/OB).Children and adolescents who are overweight or obese are becoming more commonplace across the world. It has been shown that...

Login or Register to read the full article

A new study published in the European Journal of Pediatrics suggests that a high dose of vitamin D supplementation (above 4000 IU/d) might improve insulin resistance and lower a number of cardiometabolic risk markers on child and adolescent overweight/obesity (OW/OB).

Children and adolescents who are overweight or obese are becoming more commonplace across the world. It has been shown that vitamin D deficiency is partly responsible for childhood and teenage overweight and obesity. Hao Gou and team's systematic review and meta-analysis intends to evaluate the effectiveness of vitamin D supplements on child and adolescent overweight/obesity.

From the beginning until June 20th, 2022, Embase, PubMed, Cochrane Library, and Web of science were searched. The effectiveness of vitamin D on childhood and teenage overweight/obesity was examined in randomized controlled trials (RCTs). The bias risk of the included studies was evaluated using the Cochrane bias risk assessment method, and subgroup analysis based on various administration doses was carried out. R 4.2.1 was used to perform all data analysis.

The key findings of this study were:

1. After retrieving 1502 publications, 10 studies that qualified for inclusion were made up of 595 participants in total.

2. Meta-analysis revealed no differences between the vitamin-D (Vit-D) group and the placebo group in terms of LDL, TC, BMI, TG, Ca, ALP, and PTH; however, the Vit-D group had better HOMA-IR.

3. The rise in 25-(OH)-D was not significantly different between subgroups, according to subgroup analysis (p = 0.39), although the serum 25-(OH)-D level rose in response to various Vit-D dosages.

4. A high daily dosage of vitamin D ( 4000 IU/d) may lower CRP and raise HDL levels.

In conclusion, supplementing with vitamin D wouldn't help OW/OB children and adolescents' BMI, LDL, TG, PTH, TC, Ca, and ALP levels. A high dose of vitamin D supplementation (above 4000 IU/d) might improve insulin resistance and lower a number of cardiometabolic risk markers. More large-scale, high-quality RCTs are required to produce more reliable data.

Reference:

Gou, H., Wang, Y., Liu, Y., Peng, C., He, W., & Sun, X. (2022). Efficacy of vitamin D supplementation on child and adolescent overweight/obesity: a systematic review and meta-analysis of randomized controlled trials. In European Journal of Pediatrics. Springer Science and Business Media LLC. https://doi.org/10.1007/s00431-022-04673-8

Tags:    
Article Source : European Journal of Pediatrics

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News